Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 6,781.40
+57.80 (0.86%)
At close: Jul 27, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 112.57 billion as of July 27, 2026. Its market cap has increased by 16.28% in one year.
Market Cap
112.57B
Enterprise Value
110.81B
Revenue
14.08B
Ranking
n/a
PE Ratio
34.43
Stock Price
6,781.40
ChartMarket Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 112.57B, an increase of 1,055.03%. That is a compound annual growth rate of 9.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 112.57B | 18.95% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 250.45B |
| Granules India | 206.58B |
| AstraZeneca Pharma India | 204.20B |
| Caplin Point Laboratories | 187.34B |
| Jubilant Pharmova | 152.38B |
| CORONA Remedies | 129.23B |
| Viyash Scientific | 109.55B |
| Sanofi India | 78.02B |